Cutaneous Mucormycosis Co-infection in a Patient with COVID-19
Mucormycosis is a life-threatening fungal infection usually seen in patients who are immunocompromised; however, to date, it has been rarely described in patients with COVID-19, although more recently, reports from India have described an increased incidence of these infections. This report describ...
Main Authors: | Raham Rahgoshai, Peter Goldberg, Rayhaneh Rahgoshai, Shadi Zain |
---|---|
Format: | Article |
Language: | English |
Published: |
European Medical Journal
2022-10-01
|
Series: | European Medical Journal |
Online Access: | https://www.emjreviews.com/respiratory/article/cutaneous-mucormycosis-co-infection-in-a-patient-with-covid-19/ |
Similar Items
-
Mucormycosis co-infection in COVID-19 patients: An update
by: Alkhamiss Abdullah S., et al.
Published: (2022-08-01) -
Non-COVID-19 Cutaneous Mucormycosis from a Plastic Surgical Perspective
by: Vimalendu Brajesh, et al.
Published: (2023-08-01) -
Primary cutaneous mucormycosis of the scalp
by: Bommie Florence Seo, et al.
Published: (2021-09-01) -
Mucormycosis in COVID-19 patients
by: Natarajan Sundaram, et al.
Published: (2021-01-01) -
COVID-19 associated mucormycosis: a case report in Pakistan and a review of 144 cases
by: Sheharyar Zameer, et al.
Published: (2022-10-01)